Pricing Log in Create free account
Friday 6 November 2026 Export ATRC’s income statement to Excel — free account

AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.

Revenue
+15.0%
EPS
+1,583.9%
Free cash flow
−0.73%
Total debt
−17.3%

Quarter to September 2026, against a year earlier

59.84 1.44 −2.35%
Market cap
$3.1B
P/E
199×
Fwd P/E
573×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

AtriCure, Inc. (ATRC) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, AtriCure, Inc. (ATRC) trades at a EV/Sales of 4.9×. Over the past ten years it has ranged from 2.2× (June 2026) to 16.1× (June 2021); the current reading is higher than 56% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.4× 13.29%
FY2024 3.0× (24.22%)
FY2023 4.0× (34.68%)
FY2022 6.1× (46.15%)
FY2021 11.2× 7.21%
FY2020 10.5× 99.51%
FY2019 5.3× 9.44%
FY2018 4.8× 39.21%
FY2017 3.5× (11.15%)
FY2016 3.9× (17.53%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 4.5× 98.49%
Jun 2026 2.3× (5.96%)
Mar 2026 2.4× (29.34%)
Dec 2025 3.4× 7.63%
43 more quarters

Against its own ten years

Low 2.2× High 16.1×
Ten-year median 4.5×
Current reading's percentile 55

EV/Sales against peers

Company EV/Sales
XRAY DENTSPLY SIRONA Inc. compare 1.1×
NVST Envista Holdings Corporation compare 1.5×
MMED MiniMed Group, Inc. compare 1.6×
ICUI ICU Medical, Inc. compare 2.3×
STVN Stevanato Group S.p.A. compare 2.8×
WRBY Warby Parker Inc. compare 3.2×
MMSI Merit Medical Systems, Inc. compare 3.5×
ATRC AtriCure, Inc. 4.9×
PLSE Pulse Biosciences, Inc compare 2,578×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ATRC